About Evident Vascular
Evident Vascular is a company based in San Jose (United States) founded in 2021 by Patrick Phillips, Howard Rosen, and Danielo Piazza. Evident Vascular has raised $35 million across 2 funding rounds from investors including ShangBay Capital and Vensana Capital. Evident Vascular offers products and services including IVUS Platform. Evident Vascular operates in a competitive market with competitors including AIdoc, AI Medical Service, eCential Robotics, Lantheus and Vista.ai, among others.
- Headquarter San Jose, United States
- Founders Patrick Phillips, Howard Rosen, Danielo Piazza
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Evident Vascular, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$35 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
ShangBay Capital
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Evident Vascular
Evident Vascular offers a comprehensive portfolio of products and services, including IVUS Platform.
AI-driven system for enhanced ultrasound in vascular disease interventions
People of Evident Vascular
Unlock access to complete
Software Development Team
4 people
Leadership Team
1 people
Principal Team
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of Evident Vascular
Evident Vascular has successfully raised a total of $35M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Evident Vascular
Evident Vascular has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include ShangBay Capital and Vensana Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Investments in medical technology are made by Vensana Capital.
|
Locked | Locked | Locked |
Investor details for Evident Vascular
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Evident Vascular
Investment portfolio details for Evident Vascular
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Evident Vascular
Detailed financials for Evident Vascular
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Evident Vascular Comparisons
Peer comparison for Evident Vascular
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Evident Vascular
Evident Vascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AIdoc, AI Medical Service, eCential Robotics, Lantheus and Vista.ai, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based single-screen system is provided to streamline medical imaging.
|
|
| Locked | Locked | Locked |
Provider of AI-based solution for diagnosis of cancer related lesions
|
|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
|
| Locked | Locked | Locked |
Developer of diagnostic imaging agents and targeted therapeutics
|
|
| Locked | Locked | Locked |
AI-guided software is utilized to automate MRI exams for clinicians.
|
|
| Locked | Locked | Locked |
Provider of AI-based skin cancer monitoring and detecting device for patients and doctors
|
Detailed competitors of Evident Vascular
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Evident Vascular
Complete news archive for Evident Vascular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Evident Vascular
Evident Vascular was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Evident Vascular is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Howard Rosen is the current CEO of Evident Vascular. They have also founded this company.
Evident Vascular is a funded company, having raised a total of $35M across 2 funding rounds to date.
Evident Vascular was founded in 2021 and is headquartered in San Jose, United States. AI-enabled catheter-based ultrasound technology is developed by the company within the medical device sector. An intravascular ultrasound (IVUS) platform powered by AI is provided to support image-guided therapy in peripheral vascular procedures. Operations emphasize tools for clinical applications in vascular interventions, with a focus on United States-based development and deployment.
Evident Vascular's top competitors include AIdoc, eCential Robotics and Vista.ai.
Evident Vascular offers IVUS Platform.
Evident Vascular has 2 investors. Key investors include ShangBay Capital, and Vensana Capital.